{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T14:40:02Z","timestamp":1737124802744,"version":"3.33.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,17]]},"DOI":"10.7759\/cureus.77583","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T13:58:44Z","timestamp":1737122324000},"source":"Crossref","is-referenced-by-count":0,"title":["Follicular Lymphoma Detected in a Patient Undergoing Mohs Surgery: A Case Report"],"prefix":"10.7759","author":[{"given":"Charlotte","family":"Defty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamini","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Adil A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.abd.2020.10.004","article-title":"Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations","volume":"96","author":"Bittner GC","year":"2021","unstructured":"Bittner GC, Cerci FB, Kubo EM, Tolkachjov SN. Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations. An Bras Dermatol. 2021, 96:263-277.","journal-title":"An Bras Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsc.2017.03.002","article-title":"Mohs micrographic surgery for the management of cutaneous malignancies","volume":"25","author":"Mansouri B","year":"2017","unstructured":"Mansouri B, Bicknell LM, Hill D, Walker GD, Fiala K, Housewright C. Mohs micrographic surgery for the management of cutaneous malignancies. Facial Plast Surg Clin North Am. 2017, 25:291-301. 10.1016\/j.fsc.2017.03.002","journal-title":"Facial Plast Surg Clin North Am"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2015.01.007","article-title":"Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment","volume":"72","author":"Etzkorn JR","year":"2015","unstructured":"Etzkorn JR, Sobanko JF, Elenitsas R, Newman JG, Goldbach H, SHin TM, Miller CJ. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. J Am Acad Dermatol. 2015, 72:840-50.","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000004312","article-title":"Mohs for melanoma: a review of MART-1 frozen section interpretation","volume":"50","author":"Contestable JJ","year":"2024","unstructured":"Contestable JJ, Lim GF, Willenbrink T, Zitelli JA, Brodland DG. Mohs for melanoma: a review of MART-1 frozen section interpretation. Dermatol Surg. 2024, 50:1102-8. 10.1097\/DSS.0000000000004312","journal-title":"Dermatol Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.6255","article-title":"Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers","volume":"149","author":"Alam M","year":"2013","unstructured":"Alam M, Ibrahim O, Nodzenski M, et al.. Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers. JAMA Dermatol. 2013, 149:1378-85. 10.1001\/jamadermatol.2013.6255","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson JR","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998, 9:717-20. 10.1023\/a:1008265532487","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras LR","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016, 66:443-459.","journal-title":"CA Cancer J Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2020.02.001","article-title":"Epidemiology of follicular lymphoma","volume":"34","author":"Cerhan JR","year":"2020","unstructured":"Cerhan JR. Epidemiology of follicular lymphoma. Hematol Oncol Clin North Am. 2020, 34:631-46. 10.1016\/j.hoc.2020.02.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31818e6489","article-title":"Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin","volume":"33","author":"Weinberg OK","year":"2009","unstructured":"Weinberg OK, Ma L, Seo K, et al.. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Am J Surg Pathol. 2009, 33:591-8. 10.1097\/PAS.0b013e31818e6489","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19240","article-title":"Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma","volume":"8","author":"Shastri A","year":"2017","unstructured":"Shastri A, Janakiram M, Mantzaris I, Yu Y, Londono JS, Verma AK, Barta SK. Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma. Oncotarget. 2017, 8:78410-8. 10.18632\/oncotarget.19240","journal-title":"Oncotarget"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.02.011","article-title":"Early stage extranodal follicular lymphoma: characteristics, management, and outcomes","volume":"19","author":"Andraos T","year":"2019","unstructured":"Andraos T, Ayoub Z, Nastoupil L, et al.. Early stage extranodal follicular lymphoma: characteristics, management, and outcomes. Clin Lymphoma Myeloma Leuk. 2019, 19:381-9. 10.1016\/j.clml.2019.02.011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030785","article-title":"Follicular lymphoma in the 5th edition of the WHO-classification of haematolymphoid neoplasms-updated classification and new biological data","volume":"15","author":"Kurz KS","year":"2023","unstructured":"Kurz KS, Kalmbach S, Ott M, Staiger AM, Ott G, Horn H. Follicular lymphoma in the 5th edition of the WHO-classification of haematolymphoid neoplasms-updated classification and new biological data. Cancers (Basel). 2023, 15:785. 10.3390\/cancers15030785","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.008","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dreyling M","year":"2021","unstructured":"Dreyling M, Ghielmini M, Rule S, et al.. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021, 32:298-308. 10.1016\/j.annonc.2020.11.008","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0299-0","article-title":"Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience","volume":"10","author":"Mozas P","year":"2020","unstructured":"Mozas P, Nadeu F, Rivas-Delgado A, et al.. Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience. Blood Cancer J. 2020, 10:31. 10.1038\/s41408-020-0299-0","journal-title":"Blood Cancer J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.165415","article-title":"Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","volume":"102","author":"Stevens WB","year":"2017","unstructured":"Stevens WB, Mendeville M, Redd R, et al.. Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium. Haematologica. 2017, 102:1413-23. 10.3324\/haematol.2017.165415","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore A","year":"2015","unstructured":"Pastore A, Jurinovic V, Kridel R, et al.. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 2015, 16:1111-1122. 10.1016\/S1470-2045(15)00169-2","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.134","article-title":"Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"31","author":"Miyaoka M","year":"2018","unstructured":"Miyaoka M, Kikuti YY, Carreras J, et al.. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements. Mod Pathol. 2018, 31:313-26. 10.1038\/modpathol.2017.134","journal-title":"Mod Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115845-follicular-lymphoma-detected-in-a-patient-undergoing-mohs-surgery-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T13:58:46Z","timestamp":1737122326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115845-follicular-lymphoma-detected-in-a-patient-undergoing-mohs-surgery-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.77583","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}